ResearcherUniversidad de NavarraActive in the last 2 years

Daniel Aliseda Jover

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5025-6069; OpenAlex author ID A5005439936. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials. Co-author DOI 10.1093/bjsopen/zrae087 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Mariano Ponz‐Sarvisé · 1 shared paper, 2024 · strength 0.21
- Paper Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis o… DOI 10.1093/bjsopen/zrae087 ↗
Fernando Rotellar Sastre · 1 shared paper, 2024 · strength 0.21
- Paper Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis o… DOI 10.1093/bjsopen/zrae087 ↗
Javier Rodríguez Rodríguez · 1 shared paper, 2024 · strength 0.21
- Paper Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis o… DOI 10.1093/bjsopen/zrae087 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.